Literature DB >> 9723005

Hemochromatosis: a genetic defect in iron metabolism.

E C Jazwinska1.   

Abstract

Hemochromatosis (HC), the common inherited disorder in iron metabolism, affects at least 1 in 300 Caucasians. The disorder causes inappropriately high iron absorption and accumulation of excess iron in the parenchymal cells of the major organs of the body. The gene responsible for HC has recently been cloned and is termed HFE; two missense mutations have been reported in the gene, both cause amino acid substitutions (H63D and C282Y), but to date only the C282Y mutation has been found to clearly correlate with HC in all affected populations. HFE is highly homologous to genes in the major histocompatibility complex (MHC) class I family; all of these genes encode a heterodimeric protein which is complexed to beta 2-microglobulin, a coupling essential for cell surface expression of a functional molecule. The first important step toward establishing the role of HFE in the pathogenesis of HC came with the recent observation that the C282Y mutation disrupts the binding of beta 2-microglobulin to the HFE protein and as a result the mutant molecule is not expressed on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723005     DOI: 10.1002/(SICI)1521-1878(199807)20:7<562::AID-BIES7>3.0.CO;2-M

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  3 in total

Review 1.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  The frequency of C282Y and H63D mutations in Hemochromatosis gene in native Estonians.

Authors:  P Pärlist; A V Mikelsaar; G Tasa; L Beckman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Infection with Mycobacterium avium differentially regulates the expression of iron transport protein mRNA in murine peritoneal macrophages.

Authors:  W Zhong; W P Lafuse; B S Zwilling
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.